The global demand for Bronchiectasis Market is presumed to reach the market size of nearly USD 1066.03 MN by 2030 from USD 609.87 MN in 2022 with a CAGR of 7.23% under the study period 2023 - 2030.
Bronchiectasis is a chronic condition characterized by permanent and abnormal widening of the bronchial tubes of the lungs. In this condition, the bronchial tubes become stretched, thickened, and lose their elasticity. This leads to the accumulation of mucus and makes it difficult for the airways to clear it effectively, resulting in recurrent infections and inflammation. The condition can be acquired or congenital.
The prevalence of bronchiectasis is increasing due to improved diagnostics and heightened awareness. Underlying respiratory conditions like COPD, cystic fibrosis, and previous respiratory infections contribute to the growing incidence of this condition. Advancements in diagnostic technologies, particularly high-resolution computed tomography (HRCT), have improved accuracy, leading to timely interventions and treatment. The evolving treatment landscape includes novel therapies and personalized approaches, such as inhaled medications and targeted therapies, which cater specifically to bronchiectasis patients. Research and development efforts focused on understanding the disease and developing innovative treatments contribute to market expansion. Supportive healthcare policies, government initiatives, and awareness campaigns promote its early detection and appropriate management. The ageing population, with its higher susceptibility to respiratory conditions and improved healthcare infrastructure, further drive the bronchiectasis market. Access to specialized centres and multidisciplinary care teams enhances diagnosis, management, and patient outcomes.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bronchiectasis. The growth and trends of bronchiectasis industry provide a holistic approach to this study.
This section of the bronchiectasis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Disease Type
By Severity
By Type
By Drugs Type
By Route Of Administration
By End User
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Bronchiectasis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bronchiectasis market include Abbott, HERSILL, Home Oxygen Company, Inogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc, Ache Laboratories Farmaceuticos S.A., Horizon Therapeutics plc, Janssen Pharmaceuticals, Inc., Trudell Medical International, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Novartis AG, Teva Pharmaceutical USA Inc., Sun Pharmaceutical Industries Ltd., Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . BRONCHIECTASIS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Disease Type
3.7.2 Market Attractiveness Analysis By Severity
3.7.3 Market Attractiveness Analysis By Type
3.7.4 Market Attractiveness Analysis By Drugs Type
3.7.5 Market Attractiveness Analysis By Route Of Administration
3.7.6 Market Attractiveness Analysis By End User
3.7.7 Market Attractiveness Analysis By Distribution Channel
3.7.8 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL BRONCHIECTASIS MARKET SALES BY DISEASE TYPE
5.1 Overview by Disease Type
5.2 Historical and Forecast Sales Data
5.3 Analysis by Disease Type
5.4 CF Bronchiectasis Historic and Forecast Sales by Regions
5.5 Non-CF Bronchiectasis Historic and Forecast Sales by Regions
6 . GLOBAL BRONCHIECTASIS MARKET ANALYSIS BY SEVERITY
6.1 Overview by Severity
6.2 Historical and Forecast Sales Data
6.3 Analy ...
Avail customized purchase options to meet your exact research needs: